Brief Reports
Copyright ©The Author(s) 2005.
World J Gastroenterol. Jul 21, 2005; 11(27): 4225-4229
Published online Jul 21, 2005. doi: 10.3748/wjg.v11.i27.4225
Table 1 Activity of cathepsin B and D in serum of patients with colorectal carcinoma
Healthy peopleControl serum66.9 ± 2.8
(n = 20)
Cathepsin BColorectal patientsBefore operation17.9 ± 8.51b
nmoL pNA/mL(n = 63)(serum sample a)
After operation21.0 ± 8.7f
(serum sample b)
Healthy peopleControl serum30.2 ± 2.2
(n = 20)
Cathepsin DColorectal patientsBefore operation58.7 ± 24.22d
nmoL Tyr/mL(n = 63)(serum sample a)
After operation49.9 ± 16.9h
(serum sample b)
Table 2 Correlation of serum cathepsin B and D activity and clinicopathological findings
Variablen = 63Cathepsin B (nmol/L pNA/mL)
Cathepsin D (nmol Tyr/mL)
Before operationPAfter operationPBefore operation PAfter operationP
SexM4219.1 ± 8.9NS21.7 ± 9.1NS59.4 ± 26.3NS49.5 ± 16.3NS
F2115.3 ± 6.619.6 ± 7.957.0 ± 19.250.9 ± 18.4
Age (yr)601620.4 ± 12.3NS17.4 ± 8.0P = 0.06454.2 ± 17.0NS51.7 ± 22.0NS
>604717.02 ± 6.622.4 ± 8.760.2 ± 26.149.3 ± 14.7
Tumor siteRectum3016.5 ± 7.4NS18.4 ± 7.6NS59.8 ± 21.6NS51.2 ± 19.9NS
Colon3319.1 ± 9.223.5 ± 9.157.7 ± 26.348.8 ± 13.6
HP typeAdc.5818.1 ± 8.4NS21.02 ± 8.9NS58.7 ± 24.4NS50.7 ± 17.0NS
Adc. m.510.1 ± 9.320.9 ± 7.056.0 ± 21.243.2 ± 14.2
pTpT 1+2525.3 ± 0.7P = 0.005730.3 ± 18.7NS76.8 ± 23.0P = 0.05348.8 ± 16.5NS
pT 3+45317.1 ± 8.520.3 ± 7.356.7 ± 23.650.1 ± 17.0
G24318.8 ± 8.8NS21.5 ± 9.2NS62.5 ± 25.5NS50.4 ± 17.3NS
31515.8 ± 7.319.9 ± 7.750.3 ± 18.849.2 ± 16.2
N(-)3418.5 ± 8.5NS23.9 ± 8.9P = 0.005465.9 ± 26.5P = 0.01949.7 ± 17.2NS
(+)2917.03 ± 8.417.3 ± 7.149.1 ± 16.750.3 ± 16.6